Peter Mu
Vorstandsvorsitzender bei Teamedon International, Inc.
Profil
Peter Mu is currently the President & Chief Executive Officer at Teamedon International, Inc. Prior to this, he worked as a Study Director at Labcorp Drug Development, Inc. from 2005 to 2008 and as an Associate Director at Lexicon Pharmaceuticals, Inc. from 2008 to 2009.
Dr. Mu holds a doctorate degree from North Carolina State University and an MBA from Carey Business School.
Aktive Positionen von Peter Mu
| Unternehmen | Position | Beginn |
|---|---|---|
Teamedon International, Inc.
 Teamedon International, Inc. Pharmaceuticals: MajorHealth Technology Teamedon International, Inc. develops novel therapeutics to combat leukemia. The company was founded on May 22, 2017 and is headquartered in Lewes, DE. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Peter Mu
| Unternehmen | Position | Ende |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2009 |
| COVANCE INC. | Corporate Officer/Principal | 01.04.2008 |
Ausbildung von Peter Mu
| North Carolina State University | Doctorate Degree |
| Carey Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Teamedon International, Inc.
Teamedon International, Inc. Pharmaceuticals: MajorHealth Technology Teamedon International, Inc. develops novel therapeutics to combat leukemia. The company was founded on May 22, 2017 and is headquartered in Lewes, DE. | Health Technology |
